| Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain (NCT01733914) | Peking University | 2011-09-01 |
| Dalfampridine for Imbalance in Multiple Sclerosis (NCT01444300) | Oregon Health and Science University | 2011-09-01 |
| Neuro-modulation of the Depressed Brain Using Working Memory Training and Transcranial Direct Current Stimulation (tDCS) (NCT01434836) | University of Sao Paulo | 2011-09-01 |
| Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer (NCT01453153) | Halozyme Therapeutics | 2011-09-01 |
| ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) (NCT01418092) | Alkermes, Inc. | 2011-09-01 |
| Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma (NCT01510119) | Abramson Cancer Center at Penn Medicine | 2011-09-01 |
| Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism (NCT01441557) | Centre Hospitalier Universitaire, Amiens | 2011-09-01 |
| Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection (NCT01383993) | Pfizer | 2011-09-01 |
| A Rollover Protocol for Subjects Previously Treated With AGS-003 (NCT01482949) | Argos Therapeutics | 2011-09-01 |
| Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function (NCT01438970) | Sequana Medical N.V. | 2011-09-01 |
| Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer (NCT01505075) | Sunnybrook Health Sciences Centre | 2011-09-01 |
| Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine (NCT01442675) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) (NCT01435720) | Senesco Technologies, Inc. | 2011-09-01 |
| Exercise Interventions in Parkinson's Disease (NCT01439022) | Oxford Brookes University | 2011-09-01 |
| Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials (NCT01428063) | Bristol-Myers Squibb | 2011-09-01 |
| Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis (NCT01314495) | Julian M. Mackay-Wiggan | 2011-09-01 |
| Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia (NCT01681563) | Niguarda Hospital | 2011-09-01 |
| Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder (NCT01379625) | Oregon Health and Science University | 2011-09-01 |
| The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance (NCT01412216) | University of California, San Francisco | 2011-09-01 |
| Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (NCT01204333) | Jan Stam, MD, PhD | 2011-09-01 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma (NCT01448954) | Pulmagen Therapeutics | 2011-09-01 |
| Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer (NCT01393730) | Mary-Ellen Taplin, MD | 2011-09-01 |
| Evaluating Validity of Ultrasonography in Determining Distal Radius Fracture Reduction (NCT01823692) | Isfahan University of Medical Sciences | 2011-09-01 |
| AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) (NCT01118520) | Imperial College London | 2011-09-01 |
| A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis (NCT01363388) | Amgen | 2011-09-01 |
| Image-Guided Gynecologic Brachytherapy (NCT01399658) | Dana-Farber Cancer Institute | 2011-09-01 |
| Provoked Craving Assessment (NCT01506908) | GlaxoSmithKline | 2011-09-01 |
| GS-7977 With Ribavirin for Hepatitis C (SPARE) (NCT01441180) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Sexual Assault Resistance Education for University Women (NCT01338428) | University of Windsor | 2011-09-01 |
| A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma (NCT01439568) | Eli Lilly and Company | 2011-09-01 |
| Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings (NCT01446289) | Novartis | 2011-09-01 |
| Allogeneic Transplant in HIV Patients (BMT CTN 0903) (NCT01410344) | Medical College of Wisconsin | 2011-09-01 |
| Postoperative Nausea/Vomiting and Acupressure (NCT01389570) | National Research Centre of Complementary and Alternative Medicine, Norway | 2011-09-01 |
| TRIal For Efficacy of Capre on hyperTriglyceridemiA (NCT01455844) | Grace Therapeutics Inc. | 2011-09-01 |
| Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects (NCT01399749) | Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | 2011-09-01 |
| A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients (NCT01396226) | AstraZeneca | 2011-09-01 |
| Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors (NCT01455259) | Uppsala University | 2011-09-01 |
| A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease (NCT01397578) | Genentech, Inc. | 2011-08-31 |
| A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) (NCT01414855) | Genentech, Inc. | 2011-08-31 |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer (NCT01685983) | Janssen Research & Development, LLC | 2011-08-30 |
| Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma (NCT01840007) | Centre Hospitalier Universitaire de Nice | 2011-08-30 |
| Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT01371630) | M.D. Anderson Cancer Center | 2011-08-26 |
| A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy (NCT01381874) | Janssen Research & Development, LLC | 2011-08-24 |
| A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection (NCT01147302) | Shire | 2011-08-24 |
| Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury (NCT01175993) | National Institutes of Health Clinical Center (CC) | 2011-08-24 |
| Mood and Insulin Resistance in Adolescents At-Risk for Diabetes (NCT01425905) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-08-23 |
| A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer (NCT01310231) | Ozmosis Research Inc. | 2011-08-22 |
| A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection (NCT01419067) | St. Jude Children's Research Hospital | 2011-08-22 |
| Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas (NCT01329900) | M.D. Anderson Cancer Center | 2011-08-22 |
| Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) (NCT01253460) | M.D. Anderson Cancer Center | 2011-08-22 |
| Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases (NCT01421017) | NYU Langone Health | 2011-08-19 |
| Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma (NCT01626495) | University of Pennsylvania | 2011-08-17 |
| A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy (NCT01443403) | Shionogi | 2011-08-17 |
| Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) (NCT01405911) | Merck Sharp & Dohme LLC | 2011-08-16 |
| TPI 287 in Breast Cancer Metastatic to the Brain (NCT01332630) | M.D. Anderson Cancer Center | 2011-08-16 |
| Extension Study for Patients Who Have Participated in a BMN 701 Study (NCT01435772) | BioMarin Pharmaceutical | 2011-08-15 |
| Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer (NCT01349959) | National Cancer Institute (NCI) | 2011-08-15 |
| PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection (NCT01395030) | Queen's Medical Center | 2011-08-15 |
| European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL) (NCT01260870) | Bayer | 2011-08-15 |
| Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist (NCT03070730) | Beth Israel Deaconess Medical Center | 2011-08-15 |
| Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant (NCT01431209) | University of Nebraska | 2011-08-12 |
| MR Image Guided Therapy in Prostate Cancer (NCT01377753) | National Cancer Institute (NCI) | 2011-08-12 |
| A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer (NCT01383707) | Hoffmann-La Roche | 2011-08-12 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults (NCT01416571) | GlaxoSmithKline | 2011-08-12 |
| Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload (NCT01363908) | Shire | 2011-08-10 |
| Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults (NCT01366534) | GlaxoSmithKline | 2011-08-10 |
| S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy (NCT01309672) | SWOG Cancer Research Network | 2011-08-09 |
| Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer (NCT01231659) | Novartis Pharmaceuticals | 2011-08-09 |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine (NCT01397825) | Millennium Pharmaceuticals, Inc. | 2011-08-09 |
| Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease (NCT01475162) | Medical College of Wisconsin | 2011-08-08 |
| Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer. (NCT01336634) | Novartis Pharmaceuticals | 2011-08-05 |
| A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies (NCT01384513) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-08-04 |
| Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT01348919) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-08-03 |
| Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study (NCT01375751) | Amgen | 2011-08-02 |
| ToleroMune Grass Exposure Unit Study (NCT01385800) | Circassia Limited | 2011-08-01 |
| BKM120 in Metastatic Castration-resistant Prostate Cancer (NCT01385293) | Andrew J. Armstrong, MD | 2011-08-01 |
| Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive (NCT01503983) | Fundación para el Progreso de la Oncología en Cantabria | 2011-08-01 |
| Telemedicine Versus Traditional Treatment of Muscle Tension Dysphonia (NCT01419444) | University of Arkansas | 2011-08-01 |
| Intracerebral Gene Therapy for Sanfilippo Type A Syndrome (NCT01474343) | LYSOGENE | 2011-08-01 |
| The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass (NCT01410617) | Imam Khomeini Hospital | 2011-08-01 |
| Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer (NCT01388647) | Vector Oncology | 2011-08-01 |
| Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction andpREServed Lef venTricle Ejection Fraction (ARREST) (NCT02492243) | Meshalkin Research Institute of Pathology of Circulation | 2011-08-01 |
| A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma (NCT01391130) | Eli Lilly and Company | 2011-08-01 |
| Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells (NCT02983708) | Hanyang University Seoul Hospital | 2011-08-01 |
| The Effect of Sorafenib on Portal Pressure (NCT01714609) | Yale University | 2011-08-01 |
| Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) (NCT01405820) | Biogen | 2011-08-01 |
| XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth (NCT01323231) | University of Texas at Austin | 2011-08-01 |
| VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis (NCT01390545) | Takeda | 2011-08-01 |
| The Effect of Honey on Xerostomia and Oral Mucositis (NCT01465308) | Cyprus University of Technology | 2011-08-01 |
| Phase II, Dose Finding Study of GTx-758 (NCT01393119) | GTx | 2011-08-01 |
| Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NCT01372735) | University Hospital Heidelberg | 2011-08-01 |
| Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant (NCT01426828) | University of Pennsylvania | 2011-08-01 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study (NCT01426009) | Sunovion Respiratory Development Inc. | 2011-08-01 |
| Effect of Probiotics Containing Yogurts on the Composition of Biofilms in Patients Under Orthodontic Treatment (NCT01657539) | Federal University of Pelotas | 2011-08-01 |
| Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) (NCT01418001) | Memorial Sloan Kettering Cancer Center | 2011-08-01 |
| S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer (NCT01693419) | Hallym University Medical Center | 2011-08-01 |
| Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer (NCT02002312) | Radboud University Medical Center | 2011-08-01 |
| Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome (NCT01512342) | Vrije Universiteit Brussel | 2011-08-01 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (NCT01426880) | GBG Forschungs GmbH | 2011-08-01 |
| Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction (NCT01491074) | Oslo University Hospital | 2011-08-01 |